Pancreatic Polypeptide, bovine 产品活性：Pancreatic Polypeptide, bovine 是由 36 个氨基酸组成的直链多肽，由胰腺中产生，能够抑制由分泌素和胆囊素诱导的胰腺分泌。Pancreatic Polypeptide, bovine 是神经肽 (NPY) 受体激动剂，对 NPYR4 有很高的亲和性。 产品来源： https://www.medchemexpress.cn/Pancreatic_Polypeptide,_bovine.html 研究领域：GPCR/G Protein | Neuronal Signaling 作用靶点：Neuropeptide Y Receptor In Vitro: Pancreatic Polypeptide, bovine is an agonist of NPY receptor, with high affinity at NPYR4. Pancreatic Polypeptide (1 μM) does not alter proliferation in BRIN BD11 or 1.1B4 beta-cells, but reverses the decreased cell viability in BRIN BD11 cells induced by streptozotocin. Pancreatic Polypeptide (0.1 nM-1 μM) shows no effect on insulin secretion from isolated mouse islets, and does not affect the membrane potential and (Ca2+)i levels in BRIN BD11 cells at 1 μM. Pancreatic Polypeptide, bovine inhibits secretin- and cholecystokinin-stimulated pancreatic secretion. 125I-Pancreatic Polypeptide, bovine shows no specific binding to pancreatic acini. In Vivo: Pancreatic Polypeptide (25 nmol/kg bw, i.p.) reduces glucose-stimulated insulin concentrations but shows no effect on acute feeding behaviour in overnight fasted mice. Pancreatic Polypeptide, bovine (BPP; 40 μg/kg) inhibits CCK-33-induced pancreatic protein output during the entire bovine Pancreatic Polypeptide infusion period, but shows no effect on biliary protein output during CCK-33 or CCK-8 infusion. 相关产品：BIBO3304 TFA | Galanin (1-30), human | HT-2157 | SHA 68 | Spexin | MK-0557 | BIIE-0246 | Neuropeptide Y (human,rat,mouse) (TFA) | BIBP3226 TFA | Galanin Receptor Ligand M35 | JNJ-31020028 | CGP71683 hydrochloride | [Leu31,Pro34]-Neuropeptide Y(human,rat,mouse) TFA | L 152804 | Pancreatic Polypeptide, human | RF9 | BMS-193885 | Neuropeptide Y (3-36) (human, rat) | Peptide YY (PYY) (3-36), porcine TFA | RFRP-3(human) | Peptide YY (PYY), human | Velneperit | CYM 9484 | Galnon TFA | [Leu31,Pro34]-Neuropeptide Y (porcine) | CART(55-102)(human) | M871 | Neuropeptide S(Mouse) | Peptide YY (PYY) (3-36), Human 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。